Schering-Plough subsid Warrick "no effect" on Medicaid

US drug major Schering-Plough says that the US District Court for the District of Massachusetts has ruled that the activities of its generic subsidiary, Warrick Pharmaceuticals, had no effect on Medicare reimbursement with regards to average wholesale prices for prescription products. This completely overturns a decision announced in June this year when the Court issued favorable rulings for S-P, dismissing all claims relating to its branded drug products, but found limited liability against Warrick with respect to one form of generic albuterol sulfate solution sold between the years 1998 and 1999 (see also page 2).